Biggest News Aggregation in the World
📰 Com 503 News

Com 503 News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Com 503. Real-time updates on events, politics, business and more.

Compugen joins a $848M collaboration with Gilead

Compugen Ltd. has entered another collaboration, this time exclusively licensing a preclinical antibody program against an IL-18 binding protein with Gilead Sciences Inc. Compugen will handle ongoing preclinical development and a phase I study of COM-503 to treat tumors, then Gilead receives to sole right to further continue developing the asset. Compugen is getting an up-front $60 million and is eligible for a $30 million milestone payment should the IND clear in 2024. Compugen also is eligible...
Compugen Ltd Gilead Sciences Inc Gilead Sciences Compugen Ltd Gilead Sciences Inc Com 503

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science